Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGHV1-14 is a human immunoglobulin heavy chain variable (IGHV) pseudogene located within the immunoglobulin heavy chain locus on chromosome 14[4][6]. IGHV genes as a general class provide the genetic diversity essential for antibody (immunoglobulin) specificity by contributing to the variable region of the heavy chain in B-cell receptors and secreted antibodies[5][2][3]. Pseudogenes, however, are non-functional gene copies that result from duplication or retrotransposition events and accumulate disabling mutations[4][6]. IGHV1-14, consequently, is not expressed as a functional immunoglobulin heavy chain and does not contribute to antigen recognition or immune function in humans. Functional genes from the IGHV family are, in contrast, essential for the generation of the antibody repertoire and adaptive immune response[5][3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable 1-14 (IGHV1-14).